These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 12474225)

  • 1. Uroplakin gene expression in normal human tissues and locally advanced bladder cancer.
    Olsburgh J; Harnden P; Weeks R; Smith B; Joyce A; Hall G; Poulsom R; Selby P; Southgate J
    J Pathol; 2003 Jan; 199(1):41-9. PubMed ID: 12474225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uroplakin gene expression by normal and neoplastic human urothelium.
    Lobban ED; Smith BA; Hall GD; Harnden P; Roberts P; Selby PJ; Trejdosiewicz LK; Southgate J
    Am J Pathol; 1998 Dec; 153(6):1957-67. PubMed ID: 9846985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urothelial umbrella cells of human ureter are heterogeneous with respect to their uroplakin composition: different degrees of urothelial maturity in ureter and bladder?
    Riedel I; Liang FX; Deng FM; Tu L; Kreibich G; Wu XR; Sun TT; Hergt M; Moll R
    Eur J Cell Biol; 2005 Mar; 84(2-3):393-405. PubMed ID: 15819416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract.
    Ohtsuka Y; Kawakami S; Fujii Y; Koga F; Saito K; Ando N; Takizawa T; Kageyama Y; Kihara K
    BJU Int; 2006 Jun; 97(6):1322-6. PubMed ID: 16686732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation.
    Wu RL; Osman I; Wu XR; Lu ML; Zhang ZF; Liang FX; Hamza R; Scher H; Cordon-Cardo C; Sun TT
    Cancer Res; 1998 Mar; 58(6):1291-7. PubMed ID: 9515818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origin of the tetraspanin uroplakins and their co-evolution with associated proteins: implications for uroplakin structure and function.
    Garcia-España A; Chung PJ; Zhao X; Lee A; Pellicer A; Yu J; Sun TT; Desalle R
    Mol Phylogenet Evol; 2006 Nov; 41(2):355-67. PubMed ID: 16814572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma.
    Zhang ZT; Pak J; Shapiro E; Sun TT; Wu XR
    Cancer Res; 1999 Jul; 59(14):3512-7. PubMed ID: 10416618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p63 gene expression study and early bladder carcinogenesis.
    Compérat E; Bièche I; Dargère D; Ferlicot S; Laurendeau I; Benoît G; Vieillefond A; Verret C; Vidaud M; Capron F; Bedossa P; Paradis V
    Urology; 2007 Sep; 70(3):459-62. PubMed ID: 17905096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.
    Lu JJ; Kakehi Y; Takahashi T; Wu XX; Yuasa T; Yoshiki T; Okada Y; Terachi T; Ogawa O
    Clin Cancer Res; 2000 Aug; 6(8):3166-71. PubMed ID: 10955799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential mucin MUC7 gene expression in invasive bladder carcinoma in contrast to uniform MUC1 and MUC2 gene expression in both normal urothelium and bladder carcinoma.
    Retz M; Lehmann J; Röder C; Plötz B; Harder J; Eggers J; Pauluschke J; Kalthoff H; Stöckle M
    Cancer Res; 1998 Dec; 58(24):5662-6. PubMed ID: 9865718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of circulating cancer cells expressing uroplakins and epidermal growth factor receptor in bladder cancer patients.
    Osman I; Kang M; Lee A; Deng FM; Polsky D; Mikhail M; Chang C; David DA; Mitra N; Wu XR; Sun TT; Bajorin DF
    Int J Cancer; 2004 Oct; 111(6):934-9. PubMed ID: 15300806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinoma.
    Copp HL; Chin JL; Conaway M; Theodorescu D
    Cancer; 2006 Jul; 107(1):60-6. PubMed ID: 16691580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate stem cell antigen enhancer and uroplakin II promoter based bladder cancer targeted tissue-specific vector.
    Wang D; Wang Z; Tian J; He X; Chowdhury WH; Zhang X; Li S; Rodriguez R
    Urol Oncol; 2010; 28(2):164-9. PubMed ID: 18440837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) in bladder transitional cell carcinoma.
    Ham WS; Lee JH; Yu HS; Choi YD
    Urology; 2008 Oct; 72(4):921-6. PubMed ID: 18387660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of mouse uroplakin II promoter on human bladder cancer cell line].
    Zhu HJ; Zhang ZQ; Zeng XF; Wei SS; Xu CX; Huang GJ; Guo YL
    Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):22-5. PubMed ID: 15059347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.
    Caprodossi S; Lucciarini R; Amantini C; Nabissi M; Canesin G; Ballarini P; Di Spilimbergo A; Cardarelli MA; Servi L; Mammana G; Santoni G
    Eur Urol; 2008 Sep; 54(3):612-20. PubMed ID: 17977643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
    Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uroplakin II is a more sensitive immunohistochemical marker than uroplakin III in urothelial carcinoma and its variants.
    Li W; Liang Y; Deavers MT; Kamat AM; Matin SF; Dinney CP; Czerniak B; Guo CC
    Am J Clin Pathol; 2014 Dec; 142(6):864-71. PubMed ID: 25389341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A
    Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of human uroplakin II promoter and its use in the construction of CG8840, a urothelium-specific adenovirus variant that eliminates established bladder tumors in combination with docetaxel.
    Zhang J; Ramesh N; Chen Y; Li Y; Dilley J; Working P; Yu DC
    Cancer Res; 2002 Jul; 62(13):3743-50. PubMed ID: 12097284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.